Overview
Superior Mesenteric Artery (SMA) Syndrome is an uncommon cause of proximal small-bowel obstruction, where the third part of the duodenum (D3) is compressed between the SMA and the aorta. Typical symptoms include early satiety, post-prandial epigastric pain, nausea, vomiting, bloating, and weight loss. The syndrome is classically precipitated by rapid or substantial weight loss, spinal deformity or surgery, major illness or trauma, or catabolic states that reduce the retroperitoneal fat cushion maintaining the aorto-mesenteric angle.
Epidemiology and Rarity
Superior Mesenteric Artery (SMA) Syndrome is very uncommon. Reported prevalence on imaging ranges from approximately 0.013% to 0.3%, while the true symptomatic incidence appears lower—on the order of fewer than 1 per 10,000 hospital admissions.
There is a female predominance (≈2–3:1), with most diagnoses occurring in adolescents and young adults, though it can develop at any age following rapid weight loss or major spinal surgery.
Because of its rarity and symptom overlap with more common gastrointestinal disorders, delayed diagnosis is frequent, and only a limited number of surgeons have substantial experience. This underscores the importance of referral to specialised upper-GI centres for diagnosis and management.
Pathophysiology (What actually happens)
The aorto-mesenteric fat pad normally maintains separation between the superior mesenteric artery (SMA) and the spine, preserving an aorto-mesenteric angle of approximately 38–65° and a distance of 10–30 mm.
When this fat pad is lost, the angle narrows and the distance shortens, leading to kinking or compression of the third part of the duodenum (D3). Angles of ≤22–25° and distances of ≤8–10 mm are considered strongly supportive findings in the appropriate clinical context.
Once critical narrowing occurs, patients often enter a vicious cycle:
Obstruction → Reduced intake → Further weight loss → Further narrowing
Breaking this cycle typically requires nutritional rehabilitation to restore the fat cushion or, in refractory cases, definitive surgical bypass.
Common Causes
Rapid, unintentional weight loss (e.g., following severe illness, anorexia, malignancy, hypermetabolic states).
Post-scoliosis correction or spinal surgery (lengthening/straightening reduces the mesenteric angle).
Catabolic/bedbound states, major trauma, burns, or chronic infection.
Post-bariatric surgery or other causes of significant fat loss.
Very low BMI/body habitus or congenital high ligament of Treitz (anatomic susceptibility).
Who it affects most:
While SMA syndrome can occur at any age, many series report a predominance in adolescents and young adult females with low BMI; it may also present after spinal surgery or rapid weight loss in older adults.
Diagnosis
Clinical suspicion of the correct phenotype (post-prandial pain, vomiting, weight loss).
Imaging: CT angiography is preferred for measuring the SMA–aorta angle/distance and excluding other causes.
Supportive thresholds: angle ≤22–25°, distance ≤8–10 mm.
Upper GI contrast may show proximal duodenal dilatation with an abrupt cutoff at D3.
Ultrasound can demonstrate vascular relationships in experienced hands.
Vascular Variants and Overlap (Nutcracker Syndrome)
Because the same narrowed aorto-mesenteric angle can also compress the left renal vein (Nutcracker Syndrome), we routinely screen for this — especially if there is haematuria, flank pain, pelvic congestion symptoms, or left-sided varicocele.
Where suspected, add a venous-phase assessment (CT/MR venography or Doppler) to evaluate LRV calibre/velocity ratios and collateralisation. Treating the duodenal compression with duodenojejunostomy may not resolve renal-vein symptoms; selected patients may require separate vascular/urology input (e.g., LRV transposition), whereas mild cases may improve with weight gain alone.
Management
Evidence-Based Conservative Management
Conservative management is the first-line approach when feasible, focusing on nutritional rehabilitation and postural modification to restore the aorto-mesenteric fat pad and widen the angle.
Core components:
Nutritional rehabilitation (high-calorie oral/enteral feeding; occasionally TPN) to restore the fat pad and relieve obstruction.
Postural therapy (prone or left-lateral knee-chest positioning) to reduce compression temporarily.
Electrolyte and fluid optimisation, alongside early dietetic support.
Effectiveness and limitations:
In adults with established SMA syndrome, long-term success rates range between 20% and 40%. Many patients struggle to achieve durable weight restoration and symptom resolution.
Naso-jejunal feeding can maintain nutrition but is often poorly tolerated, with discomfort, dislodgement, and poor adherence — particularly among young female adults, the most affected group.
Predictors of failure: symptom duration over 6 months, BMI below 18, and marked gastric/duodenal dilatation.
A time-limited trial (about 4–6 weeks) targeting ≥5–10% weight gain or BMI >19–20 is reasonable. If there is no apparent improvement, early definitive surgery is recommended to avoid malnutrition and recurrent obstruction.
Indications for Surgery
Failure of conservative therapy, recurrent admissions, or progressive
malnutrition/obstruction.
Surgical Treatment
The literature consistently supports duodenojejunostomy (DJ) as the most reliable operation for durable symptom relief, with excellent outcomes via both open and laparoscopic approaches.
Other described procedures include Alvear-Strong’s duodenal derotation, gastrojejunostomy, and variants of DJ (e.g., side-to-side at D3). Each has distinct limitations — such as persistent duodenal stasis, bile reflux, risk of blind/afferent loop issues, or technical complexity, particularly for minimally invasive derotation.
Our Technique & Series (RCG Health)
We have treated five consecutive SMA syndrome cases to date — four via open surgery and one laparoscopically — all with excellent clinical recovery and normalisation of nutrition on follow-up.
Our preferred reconstruction is a retrocolic Roux-en-Y duodenojejunostomy with a prophylactic jejunojejunostomy. The rationale is to mitigate afferent loop syndrome, blind-loop stasis, and small intestinal bacterial overgrowth (SIBO) by providing reliable outflow and preventing functional cul-de-sacs.
To our knowledge, employing a retrocolic Roux-en-Y DJ with a planned jejunojejunostomy specifically for primary SMA syndrome is novel for this indication in the published literature. Historically, alternatives such as the Alvear–Strong procedure, gastrojejunostomy, or side-to-side DJ at D3 have been more commonly reported. We are currently preparing this series for formal peer-reviewed submission.
Outcomes
All five patients experienced resolution of obstructive symptoms and full nutritional recovery.
No postoperative complications or symptom recurrence have been observed during the available follow-up period.
We believe this configuration offers robust decompression while minimising long-term sequelae associated with single-anastomosis bypasses or derotation procedures.
Why a reconstructive bypass (Roux-en-Y DJ) over other options?
Physiological flow with dependable duodenal decompression beyond the compression point.
Avoids bile reflux and reduces the risk of blind/afferent loop–related stasis and SIBO by adding a jejunojejunostomy.
Technically reproducible in open and minimally invasive settings; derotation (Strong’s) can be effective but is more technically demanding laparoscopically and involves extensive mobilisation with potential morbidity.
Summary
SMA Syndrome is a challenging, often under-recognised condition driven by loss of the
aorto-mesenteric fat pad and critical narrowing of the SMA–aorta angle. When
conservative therapy fails, a reconstructive bypass — specifically, retrocolic Roux-
en-Y duodenojejunostomy with jejunojejunostomy — is a safe, physiologically
sound option that, in our early series, provides durable symptom relief with a low
complication profile.
| Procedure | Representative Evidence Base (n) | Reported Success / Clinical Improvement | Key Advantages | Key Limitations / Considerations | Typical Complications |
|---|---|---|---|---|---|
| Duodenojejunostomy (DJ), Laparoscopic | ~25 (largest single-centre long-term series) + multiple smaller cohorts | ~80–100% symptom resolution; sustained BMI recovery on long-term follow-up | Physiologic bypass of D3; reproducible, minimally invasive approach; high success across centres | Requires advanced laparoscopy; mesenteric defect closure is essential | Anastomotic leak/bleed (low); stricture; ileus; internal hernia if defects not closed |
| Duodenojejunostomy (DJ), Open | Numerous historical/retrospective series | ~80–95% success in mixed cohorts | Robust exposure; suitable in hostile abdomens | Longer LOS; higher wound morbidity vs lap | Anastomotic leak/bleed; ileus; wound infection; incisional hernia |
| Strong’s Procedure (Duodenal Derotation / Division of Treitz) | Mixed age; predominantly adolescents/young adults (e.g., Ha/Alvear/Strong 33-year experience, n≈19) + selective modern reports | ~90–95% symptom relief in selected anatomy | Restores angle without enteric anastomosis | Technically demanding (esp. minimally invasive); variable durability; recurrence reported | Ileus; duodenal atony; recurrence; rare pancreatic/mesenteric injury |
| Gastrojejunostomy (GJ) | Small adult series/case reports; sometimes combined with DJ | Mixed; GOO relief, but D3 stasis may persist | Technically straightforward; rapid decompression | Does not relieve the D3 pinch directly; bile reflux; potential need for secondary DJ | Bile reflux gastritis; marginal ulcer; afferent/blind-loop issues; persistent stasis |
| Duodenoduodenostomy (DD) | ~12 (adult longitudinal series) | Clinical improvement at mid-term | Maintains duodenal continuity; targets D3 directly | Technically nuanced; smaller adult evidence base | Leak/stricture; delayed gastric emptying; pancreatitis (rare) |
| Endoscopic Ultrasound-Guided GJ (EUS-GJ) | Early adult case series/reports | High technical success; promising short-term outcomes | The least invasive option for high-risk candidates | Limited long-term data; device/stent risks; anatomic pinch persists | Stent migration/occlusion; bleeding; peritonitis; need for re-intervention |
| Roux-en-Y DJ with Planned Jejunojejunostomy (Our Technique) | 5 (our single-centre series: 4 open, one laparoscopic) | 100% symptom resolution and nutritional recovery on available follow-up | Robust decompression beyond pinch with designed outflow to minimise blind/afferent loop stasis and SIBO risk | Novel for this indication; external validation and larger cohorts pending | General anastomotic risks; internal hernia risk mitigated via defect closure; no complications to date in our series |
Patient-friendly FAQ
What is SMA Syndrome?
It’s a rare condition in which the third part of your small bowel (duodenum) is squeezed between two blood vessels (the aorta and the superior mesenteric artery), causing blockage-like symptoms.
Why does it happen?
Most often after rapid weight loss (illness, surgery, dieting), because a protective fat pad shrinks. This narrows the angle between the vessels and compresses the bowel.
Can it be treated without surgery?
We usually try nutritional therapy first to restore weight and reopen the angle. But in
many adults, long-term success is limited, and feeding tubes can be difficult to tolerate.
If symptoms persist, surgery offers a reliable solution.
What operation do you recommend?
We prefer a Roux-en-Y duodenojejunostomy with a planned jejunojejunostomy.
This safely bypasses the pinch point and helps prevent stasis-related problems.
Is the operation open or keyhole?
Both are possible. We use a minimally invasive (keyhole) approach when safe, and
an open approach when scarring, anatomy, or severe weight loss make laparoscopy
risky.
What is the recovery like?
Most patients notice rapid symptom relief, start eating more comfortably, and regain
weight over the following weeks to months. We support you with dietitians and a
structured follow-up plan.
What are the risks?
All bowel operations carry risks such as bleeding, infection, anastomotic leak, ileus,
or internal hernia (the latter mitigated by closing mesenteric defects). We explain
personalised risks and benefits before any procedure.
